2017-03-16,Recro Pharma To Present At The Oppenheimer 27th Annual Healthcare Conference
2017-03-06,Recro Pharma Reports Year End 2016 Financial Results
2017-03-06,Recro Pharma Appoints Bryan Reasons To Its Board Of Directors
2017-03-02,Recro Pharma To Present At Upcoming Investor Conferences
2017-02-27,Recro Pharma Completes Enrollment In Phase III Safety Study Of IV Meloxicam
2016-12-16,Recro Pharma Announces Closing Of $40 Million Public Offering Of Common Stock
2016-12-15,5 Stocks Insiders Love Right Now
2016-12-13,Recro Pharma Announces Pricing Of Public Offering Of Common Stock
2016-12-08,Recro Pharma Announces Proposed Public Offering Of Common Stock
2016-11-28,Recro Pharma Reports Positive Top-Line Results From Pivotal Phase III Clinical Trial Of IV Meloxicam
2016-11-10,Recro Pharma Reports Third Quarter 2016 Financial Results
2016-11-09,Recro Pharma To Present At Upcoming Investor Conferences
2016-09-07,Recro Pharma Presents Clinical Data At PAINWeek 2016
2016-09-06,Recro Pharma To Present At The Rodman & Renshaw 18th Annual Global Investment Conference
2016-08-30,Ratings Changes Today
2016-08-19,Recro Pharma Announces Closing Of Public Offering Of Common Stock
2016-08-16,Recro Pharma Announces Pricing Of Public Offering Of Common Stock
2016-08-15,Recro Pharma Announces Proposed Public Offering Of Common Stock
2016-08-11,Recro Pharma Reports Second Quarter 2016 Financial Results
2016-07-26,Recro Pharma Reports Positive Top-Line Results From Pivotal Phase III Clinical Trial Of IV Meloxicam
2016-07-05,Recro Pharma Appoints Michael Celano As Chief Financial Officer
2016-06-02,Recro Pharma To Present At The Jefferies 2016 Global HealthcareÂ Conference
2016-05-12,Recro Pharma Reports First Quarter 2016 Financial Results
2016-05-12,Recro Pharma Presents Clinical Data At American Pain Society 35th Annual Scientific Meeting
2016-03-24,Recro Pharma Reports Year End 2015 Financial Results
2016-03-07,Recro Pharma To Present At The 28th Annual ROTH Conference
2016-02-16,Recro Pharma Appoints Fred Graff As Chief Commercial Officer
2016-02-01,Recro Pharma Initiates Second Pivotal Phase III Clinical Trial Of IV Meloxicam For Acute Postoperative Pain
2016-01-27,Recro Pharma Initiates Pivotal Phase III Clinical Trial Of IV Meloxicam For Acute Postoperative Pain
2016-01-14,Recro Pharma To Present At NobleCon12 Investor Conference
2016-01-06,Recro Pharma Reports Positive Top-Line Results For Phase II Clinical Trial Of IV Meloxicam
2015-12-02,Recro Pharma Appoints Stewart McCallum, MD, As Chief Medical Officer
2015-11-24,Recro Pharma To Present At The 2015 Piper Jaffray Healthcare Conference
2015-11-13,Recro Pharma Reports Third Quarter 2015 Financial Results
2015-11-12,Recro Pharma To Participate In Upcoming Investor Conferences
2015-10-26,Recro Pharma Provides Pipeline Update
2015-09-10,Recro Pharma Appoints Karen A. Flynn To Its Board Of Directors
2015-09-10,Recro Pharma Announces Presentations At PAINWeek 2015
2015-08-14,Recro Pharma Reports Second Quarter 2015 Financial Results
2015-07-24,Recro Pharma Announces Additional Information For Phase II Clinical Trial Of Dex-IN
2015-07-20,Recro Pharma Appoints Scott Rizzo As General Manager
2015-07-17,Recro Pharma Announces Positive Top-Line Results For Phase II Clinical Trial Of Dex-IN
2015-07-07,Recro Pharma Completes $16 Million Private Financing
2015-07-01,Recro Pharma Announces $16 Million Financing
2015-06-08,3 Unusual-Volume Stocks to Trade for Breakouts
2015-05-28,Recro Pharma To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-12,Recro Pharma Reports First Quarter 2015 Financial Results
2015-04-13,Recro Pharma Completes Acquisition Of IV/IM Meloxicam And CGMP Manufacturing Facility And Business Unit From Alkermes
2015-04-09,Recro Pharma Announces Update On On-Going Phase II Clinical Trial Of Dex-IN For Treatment Of Acute Pain On Day 1 Following Surgery
2015-03-25,Recro Pharma Reports Fourth Quarter And Full Year 2014 Financial Results
2015-03-09,3 Stocks Improving Performance Of The Drugs Industry
2015-03-09,3 Stocks Driving The Health Care Sector Higher
2015-03-09,Recro Pharma To Acquire IV/IM Meloxicam And Gainesville, GA GMP Manufacturing Facility And Business Unit From Alkermes
2015-02-06,13 IPOs You Wish You Didn't Buy in 2014 (And Killed Your Portfolio)
2015-02-03,Recro Pharma Enters Into Common Stock Purchase Agreement With Aspire Capital
2015-02-02,Recro Pharma To Present At The 17th Annual BIO CEO & Investor Conference
2014-11-10,Recro Pharma Reports Third Quarter 2014 Financial Results
2014-10-29,Recro Pharma Announces Dosing Of First Patient In Phase II REC-14-013 Clinical Trial Of Dex-IN For Treatment Of Acute Pain On Day 1 Following Surgery
2014-09-10,3 Stocks Under $10 Moving Higher
2014-09-08,Recro Pharma To Present At The 2014 Aegis Healthcare & Technology Conference
2014-09-04,Recro Pharma Provides Clinical Strategy Update Following Interim Analysis For Phase IIb Clinical Trial Of Dex-IN
2014-08-12,Recro Pharma Reports Second Quarter 2014 Financial Results
,
,
,
